Peter Smits

1.6k total citations
36 papers, 989 citations indexed

About

Peter Smits is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Peter Smits has authored 36 papers receiving a total of 989 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Surgery, 24 papers in Cardiology and Cardiovascular Medicine and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Peter Smits's work include Coronary Interventions and Diagnostics (19 papers), Antiplatelet Therapy and Cardiovascular Diseases (8 papers) and Cardiac Valve Diseases and Treatments (7 papers). Peter Smits is often cited by papers focused on Coronary Interventions and Diagnostics (19 papers), Antiplatelet Therapy and Cardiovascular Diseases (8 papers) and Cardiac Valve Diseases and Treatments (7 papers). Peter Smits collaborates with scholars based in Netherlands, Italy and France. Peter Smits's co-authors include Patrick W. Serruys, David P. Foley, Evelyn Regar, Jeroen Vos, Kengo Tanabe, Muzaffer Deǧertekin, Pim de Feyter, Bernard Chevalier, Jeffrey J. Popma and Wim J. van der Giessen and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Peter Smits

35 papers receiving 961 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Smits Netherlands	16	740	515	168	161	142	36	989
Felipe Fernández‐Vázquez Spain	16	846 1.1×	1.0k 2.0×	163 1.0×	360 2.2×	164 1.2×	94	1.4k
Pablo Maureira France	17	338 0.5×	418 0.8×	148 0.9×	69 0.4×	59 0.4×	48	768
Imre Benedek Romania	12	263 0.4×	272 0.5×	90 0.5×	181 1.1×	114 0.8×	122	613
Satoshi Kainuma Japan	16	495 0.7×	466 0.9×	114 0.7×	41 0.3×	162 1.1×	98	856
Alan Nugent United States	22	604 0.8×	1.5k 2.8×	627 3.7×	169 1.0×	277 2.0×	74	2.2k
Farooq H. Sheikh United States	14	585 0.8×	412 0.8×	146 0.9×	39 0.2×	549 3.9×	103	1.3k
Samer Arnous Ireland	16	263 0.4×	457 0.9×	139 0.8×	102 0.6×	80 0.6×	53	696
Derek Filbey Sweden	13	669 0.9×	481 0.9×	117 0.7×	20 0.1×	30 0.2×	26	960
Chong Hee Lim Singapore	17	511 0.7×	222 0.4×	164 1.0×	15 0.1×	139 1.0×	47	810
Aldo Cannata Italy	21	846 1.1×	633 1.2×	358 2.1×	48 0.3×	63 0.4×	63	1.2k

Countries citing papers authored by Peter Smits

Since Specialization

Citations

This map shows the geographic impact of Peter Smits's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Smits with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Smits more than expected).

Fields of papers citing papers by Peter Smits

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Smits. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Smits. The network helps show where Peter Smits may publish in the future.

Co-authorship network of co-authors of Peter Smits

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Smits. A scholar is included among the top collaborators of Peter Smits based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Smits. Peter Smits is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tarantini, Giuseppe, Peter Smits, Thibault Lhermusier, et al.. (2023). A prospective study comparing short versus standard dual antiplatelet therapy in patients with acute myocardial infarction: design and rationale of the TARGET-FIRST trial.. PubMed. 19(3). 240–247. 3 indexed citations

Linschoten, Marijke, Sanne A. E. Peters, Maarten van Smeden, et al.. (2020). Cardiac complications in patients hospitalised with COVID-19. European Heart Journal Acute Cardiovascular Care. 9(8). 817–823. 91 indexed citations

Budding, Tjerk, et al.. (2019). De Januskop van de rechtmatigheid van het bestuur. Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam). 94(33). 2426–2433. 1 indexed citations

Berg, Victor J. van den, Sanne E. Hoeks, Jiang Ming Fam, et al.. (2018). Mid-term outcomes of the Absorb BVS versus second-generation DES: A systematic review and meta-analysis. PLoS ONE. 13(5). e0197119–e0197119. 5 indexed citations

Luca, Giuseppe De, Peter Smits, Sjoerd H. Hofma, et al.. (2017). Everolimus eluting stent vs first generation drug-eluting stent in primary angioplasty: A pooled patient-level meta-analysis of randomized trials. International Journal of Cardiology. 244. 121–127. 44 indexed citations

Vlachojannis, Georgios J., Alexander Ijsselmuiden, Jiang Ming Fam, et al.. (2017). Potentially increased incidence of scaffold thrombosis in patients treated with Absorb BVS who terminated DAPT before 18 months. EuroIntervention. 13(2). e177–e184. 15 indexed citations

Everaert, Bert, Jacques Koolen, Peter den Heijer, et al.. (2015). Appropriate use of bioresorbable vascular scaffolds in percutaneous coronary interventions: a recommendation from experienced users. Netherlands Heart Journal. 23(3). 161–165. 25 indexed citations

Şimşek, Cihan, Michael Magro, Yoshinobu Onuma, et al.. (2014). Procedural and clinical outcomes of the Absorb everolimus-eluting bioresorbable vascular scaffold: one-month results of the Bioresorbable vascular Scaffold Evaluated At Rotterdam Cardiology Hospitals (B-SEARCH). EuroIntervention. 10(2). 236–240. 14 indexed citations

Vranckx, Pascal, Freek W.A. Verheugt, Moniek PM de Maat, et al.. (2013). A randomised study of dabigatran in elective percutaneous coronary intervention in stable coronary artery disease patients. EuroIntervention. 8(9). 1052–1060. 36 indexed citations

10.

Grube, Eberhard, Bernard Chevalier, Giulio Guagliumi, et al.. (2012). The SPIRIT V Diabetic Study: A randomized clinical evaluation of the XIENCE V everolimus-eluting stent vs the TAXUS Liberté paclitaxel-eluting stent in diabetic patients with de novo coronary artery lesions. American Heart Journal. 163(5). 867–875.e1. 46 indexed citations

11.

Smits, Peter, Adrianus J. van Boven, Mariano Valdés, et al.. (2012). TCT-573 Randomized comparison of Biolimus-eluting (Nobori) and Everolimus-eluting (Xience/Promus) stents in patients with multivessel coronary artery disease: 12-month follow-up data from COMPARE II study. Journal of the American College of Cardiology. 60(17). B167–B167. 1 indexed citations

12.

Grube, Eberhard, Bernard Chevalier, Peter Smits, et al.. (2011). The SPIRIT V Study. JACC: Cardiovascular Interventions. 4(2). 168–175. 40 indexed citations

13.

Onuma, Yoshinobu, Patrick W. Serruys, Bernard De Bruyne, et al.. (2011). Comparison of in vivo acute stent recoil between the bioresorbable everolimus‐eluting coronary scaffolds (revision 1.0 and 1.1) and the metallic everolimus‐eluting stent. Catheterization and Cardiovascular Interventions. 78(1). 3–12. 93 indexed citations

14.

Stone, Gregg W., Elvin Kedhi, Patrick W. Serruys, et al.. (2010). Abstract 17024: Are the Clinical Outcomes with Everolimus-eluting versus Paclitaxel-eluting Coronary Stents Different in Patients With and Without Diabetes? Insights from the SPIRIT II, SPIRIT III, SPIRIT IV and COMPARE Randomized Trials. Circulation. 122(6). 1534–49. 1 indexed citations

15.

Fuchs, Shmuel, Ran Kornowski, Giora Weisz, et al.. (2006). Safety and Feasibility of Transendocardial Autologous Bone Marrow Cell Transplantation in Patients With Advanced Heart Disease. The American Journal of Cardiology. 97(6). 823–829. 105 indexed citations

16.

Regar, Evelyn, Pedro A. Lemos, Francesco Saia, et al.. (2004). Incidence of thrombotic stent occlusion during the first three months after sirolimus-eluting stent implantation in 500 consecutive patients. The American Journal of Cardiology. 93(10). 1271–1275. 38 indexed citations

17.

Vranckx, Pascal, David P. Foley, Pim J. de Feijter, et al.. (2003). Clinical introduction of the Tandemheart, a percutaneous left ventricular assist device, for circulatory support during high-risk percutaneous coronary intervention. PubMed. 5(1). 35–39. 60 indexed citations

18.

Feyter, Pim J. de, Peter Smits, Benno J. Rensing, et al.. (2002). Sirolimus‐Eluting Coronary Stents. Journal of Interventional Cardiology. 15(6). 467–470. 2 indexed citations

19.

Langenhove, Glenn Van, J Hamburger, Peter Smits, et al.. (2000). Evaluation of left ventricular volumes and ejection fraction with a nonfluoroscopic endoventricular three-dimensional mapping technique. American Heart Journal. 140(4). 596–602. 13 indexed citations

20.

Rienks, Rienk, Rudolf M. Verdaasdonk, Cornelius Borst, et al.. (1988). Nd‐YAG laser energy distribution in an artificial obstruction: Influence of lasing parameters in a model of laser angioplasty. Lasers in Surgery and Medicine. 8(1). 90–94. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact